Publicacións nas que colabora con P. Mulero Carrillo (15)

2022

  1. A smartphone sensor-based digital outcome assessment of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 28, Núm. 4, pp. 654-664

  2. Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset

    European Journal of Neurology, Vol. 29, Núm. 4, pp. 1075-1081

2020

  1. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

  2. New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

    Frontiers in Neurology, Vol. 11

  3. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

  4. The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

    Multiple Sclerosis Journal, Vol. 26, Núm. 13, pp. 1658-1669

2019

  1. Adherence and satisfaction of smartphone- And smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: Nonrandomized interventional feasibility study

    Journal of Medical Internet Research, Vol. 21, Núm. 8

  2. Erratum: Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study (Journal of medical Internet research (2019) 21 8 (e14863))

    Journal of medical Internet research

  3. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

    Neurology, Vol. 92, Núm. 13, pp. E1507-E1516

  4. Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

    Neurology, Vol. 92, Núm. 6, pp. 296-298

2018

  1. Ocrelizumab: a new milestone in multiple sclerosis therapy

    Therapeutic Advances in Neurological Disorders, Vol. 11

  2. Rituximab: Its efficacy, effectiveness and safety in the treatment of multiple sclerosis

    Revista de Neurologia, Vol. 66, Núm. 1, pp. 25-32

  3. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

    Multiple Sclerosis Journal, Vol. 24, Núm. 3, pp. 301-312

  4. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

    Brain, Vol. 141, Núm. 4, pp. 1075-1084

2017

  1. Lesion topographies in multiple sclerosis diagnosis: A reappraisal

    Neurology, Vol. 89, Núm. 23, pp. 2351-2356